Viruses and interferon: a fight for supremacy
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The action of interferons (IFNs) on virus-infected cells and surrounding tissues elicits an antiviral state that is characterized by the expression and antiviral activity of IFN-stimulated genes. In turn, viruses encode mechanisms to counteract the host response and support efficient viral replication, thereby minimizing the therapeutic antiviral power of IFNs. In this review, we discuss the interplay between the IFN system and four medically important and challenging viruses -- influenza, hepatitis C, herpes simplex and vaccinia -- to highlight the diversity of viral strategies. Understanding the complex network of cellular antiviral processes and virus-host interactions should aid in identifying new and common targets for the therapeutic intervention of virus infection. This effort must take advantage of the recent developments in functional genomics, bioinformatics and other emerging technologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A pivotal study in 1987 reported that a subpopulation of people with viral hepatitis treated with interferon (IFN) α — a pro-inflammatory anti-viral cytokine13 — developed depression14, demonstrating that a pro-inflammatory molecule in the periphery could directly influence mood.”
From Central regulation of stress-evoked peripheral immune responses (2023) · cites this paper as [13]
In the citing paper
“The ISG expression of all monocytes combined and all macrophages combined was higher in HCV infection compared with NS–SS and MASH (Extended Data Fig. 4e), consistent with the role of ISGs as antiviral effectors11.”
In the citing paper
“Neutrophil recruitment is induced mainly by epithelium-derived IL-8/CXCL8, Gro-α/CXCL1, and ENA-78/CXCL5 (142, 178, 223).”
From The airway epithelium: soldier in the fight against respiratory viruses (2011) · cites this paper as [142]
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae
Uetz, P., Giot, L., Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., Lockshon, D., Narayan, V., Srinivasan, M., Pochart, P., et al. (2000) · Nature · doi:10.1038/35001009 · Cited by 4,706 · cited 1×
“, and to characterize global protein–protein interaction networks in an organis”
BackgroundVirus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743 · cited 1×
“gif" NDATA ITEM> ]> Interferons (IFNs), although best known for their antiviral propertie”
Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network
Ideker, T., Thorsson, V., Ranish, J. A., Christmas, R., Buhler, J., Eng, J. K., Bumgarner, R., Goodlett, D. R., Aebersold, R., & Hood, L. (2001) · Science · doi:10.1126/science.292.5518.929 · Cited by 2,050 · cited 1×
“This confluence of genomic and information technologies brings a powerful new approach to the study of biological systems, as exemplified by recent studie”
BackgroundDer, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664 · cited 1×
“Together, these technologies provide a global perspective on the complex interactions that occur between all levels of biological information ('systems biology'), from gene expression to protein productio”
Background
Research works printed but not linked: 7
- Biron, C. A. & Sen, G. C. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 321–352 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Witherell, G. W. & Beineke, P. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response. J. Med. Virol. 63, 8–16 (2001). · doi:10.1002/1096-9071(200101)63:1<8::aid-jmv1001>3.0.co;2-k
- Sumpter, R. Jr & Gale, M. Jr. in American Society for Virology 21st Annual Meeting W33-3 (Lexington, Kentucky, 2002).
- Whitley, R. J. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2461–2509 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Roizman, B. & Knipe, D. M. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2399–2460 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Esposito, J. J. & Fenner, F. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2849–2884 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Moss, B. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2885–2922 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
Cited by
Items 801–900 of 1,000
Cerveny, M., Hessefort, S., Yang, K., Cheng, G., Gross, M., & He, B. (2003) · Virology · doi:10.1016/s0042-6822(02)00075-2 · Cited by 18
Crosstalk between Autophagy and RLR Signaling
Ke, P. (2023) · Cells · doi:10.3390/cells12060956 · Cited by 17
Kabil, M. F., Badary, O. A., Bier, F. F., Mousa, S. A., & El-sherbiny, I. M. (2023) · Journal of Liposome Research · doi:10.1080/08982104.2023.2204372 · Cited by 18
“Upon microbial invasion of the body, the immune cells excrete many bio-molecular messengers such as interferon (IFN), interleukins (IL), and granulocyte macrophage colony-stimulating factor (GM-CSF) in order to suppress the tumour cell growth and microbe growth (Katze et al .”
BackgroundCrosstalk between vault RNAs and innate immunity
Avila‐Bonilla, R. G., & Martínez-Montero, J. P. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09305-y · Cited by 17
“To make this distinction, cells have developed a plethora of pattern recognition receptors (PRRs), including Toll-like receptors (TLRs) and RIG-I-like receptors (RLRs), which are capable of identifying specific pathogen-associated molecular patterns (PAMPs), such as viral nucleic acids [2].”
BackgroundSaei, A. A., Lundin, A., Lyu, H., Gharibi, H., Luo, H., Teppo, J., Zhang, X., Gaetani, M., Végvári, Á., Holmdahl, R., et al. (2024) · Advanced Science · doi:10.1002/advs.202401502 · Cited by 18
Heynisch, B., Frensing, T., Heinze, K., Seitz, C., Genzel, Y., & Reichl, U. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.076 · Cited by 20
Wang, P., Logeart‐Avramoglou, D., Petite, H., Gonçalves, C., Midoux, P., Perche, F., & Pichon, C. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.03.045 · Cited by 19
Loh, D., & Reiter, R. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158122 · Cited by 17
Ye, W., Xu, Y., Wang, Y., Dong, Y., Xi, Q., Cao, M., Lan, Y., Zhang, L., Cheng, L., Wu, X., et al. (2014) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2014.11.009 · Cited by 18
IFN-β-Induced Alteration of VSV Protein Phosphorylation in Neuronal Cells
D’Agostino, P. M., Amenta, J. J., & Reiss, C. S. (2009) · Viral Immunology · doi:10.1089/vim.2009.0057 · Cited by 17
“Among the known cell autonomous innate immune responses, the interferon (IFN) pathway is considered to be crucial to fighting viral infections (15,23,36).”
Helbig, K. J., Yip, E., McCartney, E. M., Eyre, N. S., & Beard, M. R. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.11.008 · Cited by 17
Analysis of interferon gamma protein expression in zebrafish (Danio rerio)
Yoon, S., Alnabulsi, A., Wang, T. Y., Lee, P., Chen, T.-Y., Bird, S., Zou, J., & Secombes, C. J. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.08.023 · Cited by 17
Naggar, H. M. E., Madkour, M. S., & Hussein, H. A. (2017) · Veterinary World · doi:10.14202/vetworld.2017.187-193 · Cited by 17
“proteins which impacts metabolic pathways [43],”
Dansako, H., Naka, K., Ikeda, M., & Kato, N. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.112 · Cited by 17
Analysis of Anti-Interferon Properties of the Herpes Simplex Virus Type I ICP0 Protein
Mossman, K. L. (2005) · Humana Press eBooks · doi:10.1385/1-59259-939-7:195 · Cited by 17
Grin, P. M., Baid, K., de Jesus, H. C. R., Kozarac, N., Bell, P. A., Jiang, S. Z., Kappelhoff, R., Butler, G. S., Leborgne, N. G. F., Pan, C. L., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115080 · Cited by 19
Immuno-modulating properties of saliphenylhalamide, SNS-032, obatoclax, and gemcitabine
Söderholm, S., Anastasina, M., Islam, M. M., Tynell, J., Poranen, M. M., Bamford, D. H., Stenman, J. J. E., Julkunen, I., Šaulienė, I., Brabander, J. K. D., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.12.011 · Cited by 15
Zoladek, J., Kazzi, P. E., Caval, V., Vivet‐Boudou, V., Cannac, M., Davies, E. L., Rossi, S., Bribes, I., Rouilly, L., Simonin, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52870-w · Cited by 17
Proposed Pathway Linking Respiratory Infections with Depression
Karimi, Z., Chenari, M., Rezaie, F., Karimi, S., Parhizgari, N., & Mokhtari‐Azad, T. (2022) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2022.20.2.199 · Cited by 18
“lowing the secretion of interferon are called interferon-stimulated genes (ISGs) [20,21].”
BackgroundLi, W., Hofer, M. J., Noçon, A. L., Manders, P., & Campbell, I. L. (2013) · Virology · doi:10.1016/j.virol.2013.02.015 · Cited by 16
Sexual dimorphism in HIV-1 infection
Rechtien, A., & Altfeld, M. A. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0704-y · Cited by 18
Interferon-based treatment of chronic hepatitis C
Souvignet, C., Lejeune, O., & TREPO, C. G. (2007) · Biochimie · doi:10.1016/j.biochi.2007.04.017 · Cited by 16
Rizvi, S. M., & Raghavan, M. (2002) · Journal of Virology · doi:10.1128/jvi.77.1.701-708.2003 · Cited by 17
Microcalorimetric studies of the effects on the interactions of human recombinant interferon-α2a
Huang, S., Lin, F., & Yang, C.-P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.01.003 · Cited by 16
Combinatorial immunotherapies for infectious diseases
Hengel, H., & Masihi, K. N. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00028-6 · Cited by 16
Cox, N. J., Neumann, G., Donis, R. O., & Kawaoka, Y. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0238 · Cited by 16
Helbig, K. J., & Beard, M. R. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.9 · Cited by 15
Cooperative Virus-Virus Interactions: An Evolutionary Perspective
Segredo-Otero, E. A., & Sanjuán, R. (2022) · BioDesign Research · doi:10.34133/2022/9819272 · Cited by 16
“IFN is released from infected cells and activates an antiviral state in neighboring cells [75, 76], but the onset of this process takes several hours, at least in cell cultures.”
BackgroundAutophagy as an innate immunity response against pathogens: a Tango dance
Aguilera, M. O., Delgui, L. R., Reggiori, F., Romano, P. S., & Colombo, M. I. (2023) · FEBS Letters · doi:10.1002/1873-3468.14788 · Cited by 16
Barcelos, L. D. S., Ford, A. K., Frühauf, M. I., Botton, N. Y., Fischer, G., & Maggioli, M. F. (2024) · Viruses · doi:10.3390/v16111753 · Cited by 21
Rajwani, J., Vishnevskiy, D. A., Turk, M., Naumenko, V., Gafuik, C., Kim, D., Mah, L. K., Snelling, S., Gonzales, G. A., Xue, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54111-6 · Cited by 19
Mitochondria-dependent innate immunity: A potential therapeutic target in Flavivirus infection
Losarwar, S., Pancholi, B., Babu, R., & Garabadu, D. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114551 · Cited by 17
Differential expression of microRNAs in porcine parvovirus infected porcine cell line
Li, X., Zhu, L., Liu, X., Sun, X., Zhou, Y., Lang, Q., Li, P., Cai, Y., Qiao, X., & Xu, Z. (2015) · Virology Journal · doi:10.1186/s12985-015-0359-4 · Cited by 17
“Discussion and conclusion Previous studies have shown that viruses have evolved a wide variety of means for resisting the host immune system [8–10].”
BackgroundMolecular characterization and biological activity of bovine interferon-omega3
An, D., Guo, Y., Bao, J., Luo, X., Liu, Y., Ma, B., Gao, M., & Wang, J. (2017) · Research in Veterinary Science · doi:10.1016/j.rvsc.2017.01.028 · Cited by 16
Eledge, M. R., Zita, M. D., & Boehme, K. W. (2019) · Current Clinical Microbiology Reports · doi:10.1007/s40588-019-00121-8 · Cited by 19
Gong, M., Wang, F., Liu, W., Chen, R., Wu, H. J., Zhang, W., Yu, X., Han, R., Liu, A., Chen, Y., et al. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz136 · Cited by 16
“SVECs purity was greater than 95% based on assessment using immunostaining for pan-cytokeratin, an epithelial cell marker [16].”
BackgroundPan, Y., Cheng, A., Zhang, X., Wang, M., Chen, S., Zhu, D., Liu, M., Zhao, X., Yang, Q., Wu, Y., et al. (2020) · Aging · doi:10.18632/aging.103759 · Cited by 19
Interferon Epsilon Signaling Confers Attenuated Zika Replication in Human Vaginal Epithelial Cells
Mungin, J. W., Chen, X., & Liu, B. (2022) · Pathogens · doi:10.3390/pathogens11080853 · Cited by 14
Axin1: A novel scaffold protein joins the antiviral network of interferon
Guo, Y., Bamunuarachchi, G., Vaddadi, K., Zhu, Z., Gandikota, C., Ahmed, K., Pushparaj, S., More, S., Xiao, X., Yang, X., et al. (2022) · Molecular Microbiology · doi:10.1111/mmi.14995 · Cited by 15
“However, viruses can block nearly all aspects of the IFN regulatory pathway through intimate interplay to avoid compromising virus replication (Katze et al., 2002).”
BackgroundSeebach, E., Elschner, T., Kraus, F. V., Souto‐Carneiro, M., & Kubatzky, K. F. (2023) · Inflammation · doi:10.1007/s10753-023-01824-3 · Cited by 17
“In virus infections, IFN-β interferes with cellular proliferation and induces the production of ISGs that impairs viral replication [45].”
BackgroundSakamoto, N., Yoshimura, M., Kimura, T., Toyama, K., Sekine‐Osajima, Y., Watanabe, M., & Muramatsu, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.167 · Cited by 15
Tsugawa, Y., Kato, H., Fujita, T., Shimotohno, K., & Hijikata, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089869 · Cited by 16
“during the first days of infection [5].”
Fiorito, F., Cantiello, A., Granato, G. E., Navas, L., Diffidenti, C., Martino, L. D., Maharajan, V., Olivieri, F., Pagnini, U., & Iovane, G. (2016) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2016.07.006 · Cited by 15
LGP2 plays a critical role in MDA5-mediated antiviral activity against duck enteritis virus
Huo, H., Zhao, L., Wang, D., Chen, X., & Chen, H. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.10.006 · Cited by 15
Japanese Encephalitis Virus: The Complex Biology of an Emerging Pathogen
Shailendra, K., Tiwari, S., Saxena, R., Mathur, A., & Nair, M. P. N. (2013) · InTech eBooks · doi:10.5772/54111 · Cited by 15
Tsukahara, T., Kim, S., & Taylor, M. W. (2006) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2006.01.002 · Cited by 17
Studying Human Pathogens in Animal Models: Fine Tuning the Humanized Mouse
Lassnig, C., Kolb, A. F., Strobl, B., Enjuanes, L., & Müller, M. M. (2005) · Transgenic Research · doi:10.1007/s11248-005-1676-y · Cited by 15
“Co-evolution has led to selection and adaptation of both the virus and the host (Katze et al., 2002; van Kooyk & Geijtenbeek, 2003 and refs.”
BackgroundImmunogenicity of Cytopathic and Noncytopathic Viral Vectors
Plesa, G., McKenna, P. M., Schnell, M. J., & Eisenlohr, L. C. (2006) · Journal of Virology · doi:10.1128/jvi.00084-06 · Cited by 15
“First, early after infection, cells infected with cytopathic viruses are expected to drive higher levels of “danger” signaling via release of heat shock proteins, double-stranded RNA, and other factors (20, 30, 37).”
BackgroundKobayashi, N., Bagheri, N., Nedrud, J. G., Strieter, R. M., Tomino, Y., Lamm, M. E., & Emancipator, S. N. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00258.x · Cited by 16
“[39, 40].”
Microbes and their products—physiological effects upon mammalian mucosa
Viswanathan, V. K., Sharma, R., & Hecht, G. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.09.005 · Cited by 17
Structural Virology: The Key Determinants in Development of Antiviral Therapeutics
Handa, T., Saha, A., Narayanan, A., Ronzier, E., Kumar, P., Singla, J., & Tomar, S. (2025) · Viruses · doi:10.3390/v17030417 · Cited by 18
“These strategies allow viruses to avoid immune detection and maintain their infectivity [115].”
Ahluwalia, P. K., Ahluwalia, M., Vaibhav, K., Mondal, A. K., Sahajpal, N., Islam, S. U., Fulzele, S., Kota, V. K., Dhandapani, K. M., Baban, B., et al. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00230-1 · Cited by 14
Zhu, C., Li, J., Tian, C., Qin, M., Wang, Z., Shi, B., Qu, G., Wu, C., & Nan, Y. (2021) · Vaccines · doi:10.3390/vaccines9020164 · Cited by 14
“Thus, all IFNs stimulate cells via binding of their corresponding receptors to trigger JAK/STAT pathway activation [12] that subsequently evokes a sequential cascade of events leading to increased expression of IFN-stimulated genes (ISGs) [13].”
BackgroundhnRNPs in antiviral innate immunity
Maceratessi, S., & Sampaio, N. G. (2024) · Immunology · doi:10.1111/imm.13846 · Cited by 14
Dong, S., Yin, Y., Shen, S., Guo, Y., Gao, M., Zhang, W., Zhu, Y., Yu, R., Shi, Z., & Li, Z. (2012) · Research in Veterinary Science · doi:10.1016/j.rvsc.2011.12.006 · Cited by 14
Landolt, G. A., Townsend, H. G. G., & Lunn, D. P. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2406-4.50017-x · Cited by 21
Hemin protects against Zika virus infection by disrupting virus-endosome fusion
Xu, M., Wu, B., Huang, G.-G., Feng, C., Wang, X., Wang, H., Wu, Y., & Tang, W. (2022) · Antiviral Research · doi:10.1016/j.antiviral.2022.105347 · Cited by 15
He, J., Munir, F., Ragoonanan, D. S., Zaky, W. T., Khazal, S. J., Tewari, P., Fueyo-Margareto, J., Gomez‐Manzano, C., & Jiang, H. (2023) · Immuno · doi:10.3390/immuno3010004 · Cited by 17
Wang, S., Zheng, G., Zhao, L., Xu, F., & Qian, J. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12629 · Cited by 14
“Type I interferons (IFNs), primarily IFN-a/b, are produced by host cells as ‘early’ antiviral agents [5, 6] and are recognized as a critical part of the host innate immune response to virus infection.”
BackgroundA method to measure an indicator of viraemia in Atlantic salmon using a reporter cell line
Collet, B., Urquhart, K., Noguera, P. A., Larsen, K. H., Lester, K., Smail, D. A., & Bruno, D. W. (2013) · Journal of Virological Methods · doi:10.1016/j.jviromet.2013.04.009 · Cited by 14
Gelderblom, H. C., Zeuzem, S., Gelderblom, H. C., Zeuzem, S., Weegink, C. J., Forestier, N., Gelderblom, H. C., Zeuzem, S., Weegink, C. J., Forestier, N., et al. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802044210 · Cited by 14
“IFN-a is a pleiotropic cytokine with direct antiviral, immunomodulatory, and both pro- and anti-inflammatory effects [15,28].”
BackgroundWang, Y., Li, Y., Wang, X., Li, J., Song, L., & Ho, W. (2012) · Innate Immunity · doi:10.1177/1753425912460414 · Cited by 18
“The action of IFN on virus-infected cells is to elicit an antiviral state, which is characterized by the induction of IFN-stimulated genes (ISGs).(24) We thus examined the expression of several key IFN-inducible genes in HCV JFH-1-infected Huh7 cells incubated with SN from LX-2 cell cultures stimulated with 50pppdsRNA.”
BackgroundAntiviral activity of Engystol® and Gripp-Heel®: an in-vitro assessment
Roeska, K., & Seilheimer, B. (2010) · Journal of Immune Based Therapies and Vaccines · doi:10.1186/1476-8518-8-6 · Cited by 16
“The synthesis of type I IFN is triggered by viral infection acting on IFN-regulatory factors (IRFs), while type II IFN is induced by mitogenic or antigenic stimuli [14].”
Tu, Y., Wang, G., Wang, Y., Chen, W., Zhang, L., Liu, Y., Jiang, C., Wang, S., Bu, Z., & Cai, X. (2016) · Microbiological Research · doi:10.1016/j.micres.2016.05.009 · Cited by 14
Strouts, F. R., Popper, S. J., Partidos, C. D., Stinchcomb, D. T., Osorio, J. E., & Relman, D. A. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004731 · Cited by 15
MiR-525-3p mediates antiviral defense to rotavirus infection by targeting nonstructural protein 1
Tian, Z., Zhang, J., He, H., Li, J., Wu, Y., & Shen, Z. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.09.003 · Cited by 14
Effects of hepatitis E virus infection on interferon production via ISG15
Wang, M., Huang, Y. R., He, M., Peng, W., & Tian, D. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i20.2173 · Cited by 13
Mockus, T. E., Netherby, C. S., Atkins, H., Lauver, M. D., Jin, G., Ren, H. M., & Lukacher, A. E. (2020) · Journal of Virology · doi:10.1128/jvi.02038-19 · Cited by 15
Wang, F., Barrett, J. W., Shao, Q., Gao, X., Dekaban, G. A., & McFadden, G. (2009) · Virology · doi:10.1016/j.virol.2009.02.013 · Cited by 14
“Consequently, the expression of multiple ISG products such as ISG15, myxovirus resistance (Mx) and 2′–5′-oligoadenylate synthetase (OAS) leads to the establishment of an antiviral state (Katze et al., 2002; Randall and Goodbourn, 2008; Samuel, 2001; Stetson and Medzhitov, 2006).”
BackgroundVANDERSLUIJS, K., VANELDEN, L., Xiao, Y., Arens, R., Nijhuis, M., Schuurman, R., Florquin, S., Jansen, H. M., Lutter, R., & VANDERPOLL, T. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.01.007 · Cited by 14
“IFN-␥ is considered to be the most important antiviral mediator during influenza infection and induces several antiviral mechanisms, including inhibition of viral replication in virus-infected cells (Katze et al., 2002) .”
BackgroundAction mechanisms and characteristics of miRNAs to regulate virus replication
Yao, J., Zhu, Y., Zhang, G., Zhou, X., Shang, H., Li, L., & Xu, T. (2023) · Virology · doi:10.1016/j.virol.2023.109966 · Cited by 17
Chung, Y. H., Zhao, Z., Jung, E., Omole, A. O., Wang, H., Sutorus, L., & Steinmetz, N. F. (2024) · Advanced Science · doi:10.1002/advs.202308237 · Cited by 15
Sharif‐Askari, F. S., Alsayed, H. A. H., Sharif‐Askari, N. S., Saddik, B. A., Hussain, A. A. S., & Halwani, R. (2024) · Public Health · doi:10.1016/j.puhe.2024.02.031 · Cited by 14
Peptide-coated DNA nanostructures as a platform for control of lysosomal function in cells
Elblová, P., Lunová, M., Henry, S. J. W., Tu, X., Calé, A., Dejneka, A., Havelková, J., Petrenko, Y., Jirsa, M., Stephanopoulos, N., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155633 · Cited by 18
Onufer, A. P., Mell, J. C., Cort, L., Rao, A. S., Mdluli, N. V., & Carey, A. J. (2025) · Mucosal Immunology · doi:10.1016/j.mucimm.2025.02.002 · Cited by 14
“10 Indeed, in neonatal TIIECs with defective IFN-I signaling, there is a relative upregulation of developmental pathways and cell repair mechanisms relative to WT controls.”
Octaviani, C. P., Huang, P., Peng, B., Gray, G. C., & Tseng, C.-T. K. (2025) · Scientific Reports · doi:10.1038/s41598-025-93493-5 · Cited by 18
“Interferons then promote an antiviral state, blocking virus replication at many levels through the upregulation of interferon-stimulated genes (ISGs) 30,31 .”
The X awakens: multifactorial ramifications of sex-specific differences in HIV-1 infection
Hagen, S. H., & Altfeld, M. A. (2016) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30473-8 · Cited by 13
“Type I interferons activate the expression of interferon-stimulated genes (ISG) that can suppress viral replication [24], but also might contribute to higher and chronic immune activation of CD4 and CD8 T cells during persistent HIV-1 infection in females [22], which is reflected by increased levels of ISGs ex vivo [2…”
BackgroundHepatic IFN-Induced Protein with Tetratricopeptide Repeats Regulation of HCV Infection
Ishida, Y., Kakuni, M., Bang, B., Sugahara, G., Lau, D., Tateno, C., Li, M., Gale, M., & Saito, T. (2019) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2018.0103 · Cited by 16
Self-citationXu, Z. L., Li, X., Xue, J.-C., Shen, L., Zheng, W., Yin, S., & Xu, J. C. (2020) · Virology · doi:10.1016/j.virol.2020.06.004 · Cited by 13
“It is believed that the powerful strategies of JEV to evade or suppress the host innate immune response may be one of the molecular mechanisms contributing to JEV virulence (Ye et al., 2017; Garcia-Sastre, 2002; Katze et al., 2002).”
Antibody protection from SARS-CoV-2 respiratory tract exposure and infection
Chen, A., Wessler, T., & Forest, M. G. (2022) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2022.111334 · Cited by 13
“Interferons also play an important role in signaling the immune system to enhance its defenses (Le Page et al., 2000; Katze et al., 2002), and a companion submission examines this role in protecting against alveolar pneumonia (Aristotelous et al.”
Extracellular Vesicles and Their Role in Lung Infections
Hambo, S., & Harb, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216139 · Cited by 16
“This hsa-miR-1975 is delivered into the surrounding neighboring cells by exosomes, where it fuses with other antiviral proteins or nucleotides to produce interferon, thereby blocking viral replication when it invades the cells [59,60].”
BackgroundMinami, R., Takahama, S., Kaku, Y., & Yamamoto, M. (2016) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2016.09.003 · Cited by 13
Mba, I. E., Sharndama, H. C., Osondu-chuka, G. O., & Okeke, O. P. (2021) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2021.1916071 · Cited by 13
“Antiviral properties produced by IFN can truncate any of the viral life cycle steps [123].”
BackgroundZong, X., Cai, J., Chen, J., Wang, P., Zhou, G., Chen, B., Li, W., & Ji, M. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.006 · Cited by 14
Cloning and biological characterization of buffalo (Bubalus bubalis) interferon-γ
Premraj, A., Sreekumar, E., & Rasool, T. J. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.03.012 · Cited by 13
Luo, X., Pan, R., Wan, C., Liu, X., Wu, J., & Pan, Z. (2009) · Virus Research · doi:10.1016/j.virusres.2009.09.011 · Cited by 13
ILCs—Crucial Players in Enteric Infectious Diseases
Leupold, T., & Wirtz, S. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214200 · Cited by 13
Campos, M. A., Zolini, G. D. P., & Kroon, E. G. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2903102 · Cited by 13
“This activation initiates a phosphorylation cascade through IRF-3 and IRF-7, resulting in the induction of type I interferon (type I IFN) [14,16–18].”
BackgroundPathogenesis, Diagnosis, and Treatment of Infectious Rhinosinusitis
Huang, F., Liu, F., Zhen, X., Gong, S., Chen, W., & Song, Z. (2024) · Microorganisms · doi:10.3390/microorganisms12081690 · Cited by 19
“All three types of IFNs can directly or indirectly mediate antiviral responses [50,51].”
BackgroundKang, N., Kim, E.-A. L., Park, A., Heo, S., Heo, J.-H., Lee, W.-K., Ryu, Y.-K., & Heo, S. (2024) · Marine Drugs · doi:10.3390/md22090397 · Cited by 12
“Interferons (IFNs) are cytokines secreted by host cells during an antiviral immune response, inhibiting the translation of viral proteins and viral replication [38,39].”
BackgroundPadilha, M. D. M., Melo, F. T. D. V., Laurentino, R. V., da Silva, A. N. M. R., & Feitosa, R. N. M. (2024) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2024.104468 · Cited by 15
Lin, M., Yang, C., Kuo, S., Wu, C., Chang, Y., & Yang, P. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5244-x · Cited by 12
“In response to interferon, STAT1 is upregulated, and its phosphorylated form binds to the promoter region of interferon-stimulated genes.(30,32) A predominance of STAT1 activation promotes the M1 polarization of TAM.”
BackgroundMaldonado, N., Fredericksen, F., Espiñeira, C., Toledo, C., Oltra, J., de la Barra, V., Fernandez‐Senac, C., Salvador, J., Villalba, M., & Olavarría, V. H. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.09.018 · Cited by 13
Morin, B. M., Rabah, N., Boretto, J., Tolou, H., Alvarez, K., & Canard, B. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2010.06.003 · Cited by 12
Role of γδ T cells in West Nile virus-induced encephalitis: Friend or foe?
Wang, T. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.10.004 · Cited by 13
“munity against lethal WNV encephalitis (Shahar et al., 1990; Anderson and Rahal, 2002; Katze et al., 2002; Lucas et al., 2003; Wang et al., 2003a; Samuel and Diamond, 2005; Shrestha et al., 2006).”
Mi, Z., Ma, Y., & Tong, Y. (2012) · Virology Journal · doi:10.1186/1743-422x-9-145 · Cited by 12
“Considering the important role of innate immune response in controlling virus transmission and pathogenesis [11,12], in the current study, a novel genotype H5N1 strain A/tree sparrow/Henan/1/04(H5N1) isolated from a tree sparrow in Mainland China was chosen [13] and its interferon-beta (IFN-β) induction and modulation…”
MethodA systematic analysis of a mi-RNA inter-pathway regulatory motif
Carlo, S. D., Politano, G. M. M., Savino, A., & Benso, A. (2013) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-3-20 · Cited by 12
“In particular, after IFN-γ stimulation, STAT1 forms homodimers or heterodimers with STAT3 for binding with GAS (interferon-gamma activated sequence) promoter elements and their further regulation [54].”
Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform
Sa-nguanmoo, N., Namdee, K., Khongkow, M., Ruktanonchai, U., Zhao, Y., & Liang, X. (2021) · Nano Research · doi:10.1007/s12274-021-3832-y · Cited by 13
Hu, J., Lu, R., Zhang, Y., Li, W., Hu, Q., Chen, C., Liu, Z., Zhang, W., Ling, C., Xu, R., et al. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00687-1 · Cited by 12
Self-citationAberrant expression of RUNX3 in patients with immune thrombocytopenia
Qiao, J., Liu, Y., Wu, Y., Li, X., Zhu, F., Xia, Y., Yao, H., Chu, P., Li, H., Ma, P., et al. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.06.008 · Cited by 12
Metadata
- Authors
- Katze, M. G., He, Y., & Gale, M.
- Affiliations
- University of Washington (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Katze, Michael G.
- Venue
- Nature Reviews Immunology
- Published
- 2002-09-01
- Volume
- 2
- Issue
- 9
- Pages
- 675-687
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2079295092
- Cited by
- 1,419
- References
- 138
- Citations by year
- 2026: 30 · 2025: 62 · 2024: 89 · 2023: 82 · 2022: 67 · 2021: 48 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 38 · 2016: 41 · 2015: 40 · 2014: 55 · 2013: 58 · 2012: 55
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon, antiviral immunity, host-virus interaction, interferon-stimulated genes, viral evasion of host defense, influenza virus, hepatitis C virus, herpes simplex virus, vaccinia virus, antiviral drug targets
- MeSH terms
- Animals, Hepatitis C, Herpes Simplex, Humans, Interferon Type I, Membrane Glycoproteins, Orthomyxoviridae, Orthomyxoviridae Infections, Receptors, Cell Surface, Vaccinia, Vaccinia virus, Virus Diseases, Virus Replication, Hepacivirus, Simplexvirus, Computational Biology, Databases as Topic, Genomics, Drosophila Proteins, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.